These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 30067557

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
    Álvarez-Twose I, Jara-Acevedo M, Morgado JM, García-Montero A, Sánchez-Muñoz L, Teodósio C, Matito A, Mayado A, Caldas C, Mollejo M, Orfao A, Escribano L.
    J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Systemic mastocytosis with diffuse cutaneous involvement and haematological disease presenting in utero treated unsuccessfully with vincristine.
    Angus J, Leach IH, Grant J, Ravenscroft JC.
    Clin Exp Dermatol; 2008 Jan; 33(1):36-9. PubMed ID: 17983456
    [Abstract] [Full Text] [Related]

  • 7. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
    Doyle LA, Sepehr GJ, Hamilton MJ, Akin C, Castells MC, Hornick JL.
    Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: a case review.
    Ustun C, Savage NM, Gotlib J, Bhalla K, Manaloor E, George TI.
    Am J Hematol; 2012 Feb; 87(2):191-3. PubMed ID: 22081475
    [No Abstract] [Full Text] [Related]

  • 10. Kit Mutations: New Insights and Diagnostic Value.
    Falchi L, Verstovsek S.
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):411-428. PubMed ID: 30007460
    [Abstract] [Full Text] [Related]

  • 11. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F, Escribano L, Sotlar K, Nunez R, Schuetze K, Valent P, Horny HP.
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The genetic basis of mast cell activation disease - looking through a glass darkly.
    Molderings GJ.
    Crit Rev Oncol Hematol; 2015 Feb; 93(2):75-89. PubMed ID: 25305106
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Coexistence of three variants of cutaneous mastocytosis as the presenting sign of systemic mastocytosis with somatic c-kit D816V point mutation.
    Lesnoni La Parola I, Cannistraci C, Izzi S, Pisani F, Amantea A, Rongioletti F.
    Int J Dermatol; 2014 Oct; 53(10):1265-8. PubMed ID: 24738598
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Cutaneous mastocytosis].
    Flageul B.
    Rev Prat; 2006 Oct 31; 56(16):1745-51. PubMed ID: 17315498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.